| Financial Year |
March 31 2023 |
| Monetary Funds |
165,178,291.49 |
| Held-for-trading Financial Assets |
500,000.00 |
| Notes Receivable |
938,519.25 |
| Accounts Receivable |
503,767,259.63 |
| Advances to Suppliers |
1,281,813.85 |
| Other Receivables |
2,122,904.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,392,387.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,520,207.03 |
| Total Current Assets |
1,470,716,437.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,853,100.00 |
| Long-term Equity Investment |
33,241,737.33 |
| Investment Properties |
15,088,647.22 |
| Fixed Assetes |
89,694,369.21 |
| Under-construction Projects |
972,553,292.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,145,370.98 |
| R&D expenses |
-- |
| Goodwill |
73,053,523.19 |
| Long-Term Deferred and Prepaid Expenses |
4,460,714.38 |
| Deferred Income Tax Assets |
12,680,185.79 |
| Other Non-Current Assets |
673,647,674.90 |
| Sub-Total of Non-Current Assets |
1,945,598,302.36 |
| Total Assets |
3,416,314,740.00 |
| Short-Term Loans |
477,645,686.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,292,824.00 |
| Accounts Payable |
822,113,598.01 |
| Accounts Received In Advance |
228,872.13 |
| Employee Compensation Payable |
5,678,155.85 |
| Taxes Payable |
6,159,570.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
85,876,164.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,632,694.16 |
| Other Current Liabilities |
204,209,371.96 |
| Sub-Total of Current Liabilities |
1,761,314,594.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,920,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,023,399.20 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,593,170.26 |
| Total Liabilities |
1,774,907,764.54 |
| Paid-In Capital(Or Share Stock) |
325,733,572.00 |
| Capital Surplus |
459,057,480.49 |
| Surplus Reserve |
63,035,037.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
506,047,360.37 |
| Minority Stockholder's Interest |
287,533,525.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,353,873,450.19 |
| Owner's Equity（Stockholder's Equity） |
1,641,406,975.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,416,314,740.00 |
